TOFASUN-5
Description
Tofasun(tofacitinib) is FDA approved for the treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA). It is a second-generation selective Janus kinase (JAK) inhibitor targeting the JAK1 enzyme.
Tags
Packing
10×1×10
Share Product
Related Products
Post your Requirement
You are looking for?
Requirement Emergency
Call-Time Preference
